Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Andrew Saik currently holds 187,432 shares of AUXILIUM PHARMACEUTICALS INC (AUXL), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Andrew Saik has been a net buyer of AUXL stock. They have purchased $58.4K and sold $46.5K worth of shares.
Andrew Saik's most recent insider trade was on Jun 24, 2026, when they sold 5,696 shares at $8.16 per share.
Andrew Saik serves as Executive at AUXILIUM PHARMACEUTICALS INC (AUXL). They have executed 29 insider transactions totaling $104.9K over their tenure at the company.
Andrew Saik holds the position of Executive at AUXILIUM PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 12 years and currently hold a stake valued at $0.
Andrew Saik has shown a buying trading pattern, with $58.4K in total purchases and $46.5K in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Andrew Saik was on Nov 8, 2023, when they sold $859.6K worth of ICPT shares. This transaction involved 45,244 shares at $19.00 per share.
Andrew Saik currently owns 187,432 shares of AUXILIUM PHARMACEUTICALS INC (AUXL), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Andrew Saik's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Andrew Saik has 29 Form 4 filings on record as an insider at AUXILIUM PHARMACEUTICALS INC.
Set alerts for Andrew Saik and 40,000+ other insiders.